arrow
L

Ludvig A. Munthe

Oslo University Hospital
H指数:26
被引数:3,795

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TCR T cells targeting IgA- and IgG-expressing multiple myeloma

靶向表达IgA和IgG的多发性骨髓瘤的TCR T细胞

Blood
IF23.1
2026-03-040
OA
Safety and efficacy of daratumumab in immune thrombocytopenia

达雷木单抗在免疫性血小板减少症中的安全性与有效性

2025-08-070
OAAI
Targeting proteostasis in multiple myeloma through inhibition of LTK

通过抑制LTK靶向多发性骨髓瘤的蛋白质稳态

Leukemia
IF13.4
2025-07-090
OAAI
Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease

炎症性肠病期间SARS-CoV-2混合免疫力不足

2025-02-010
OAAI
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
2025-01-010
PRE
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
2024-10-011
OAAI
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study
2024-02-222
OAAI
Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence( vol 14, 1265044, 2023)

人工智能鉴定的免疫原性SARS-CoV-2 T细胞表位的实验验证 (第14卷,1265044,2023)

2024-02-210
OAAI
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination

使用药物的人对SARS-CoV-2的预先存在的T细胞交叉反应性没有增加,但在标准mRNA疫苗接种后产生正常的多功能T细胞反应

2024-01-170
OAAI
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients

肾移植受者的杂交免疫和SARS-CoV-2-vaccine免疫

2023-11-015
OAAI
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study

SARS-CoV-2疫苗接种的造血细胞移植受者中强大的刺突特异性CD4和CD8 T细胞反应: 一项前瞻性队列研究

2023-07-075
OAAI